CO7350656A2 - Synergistic composition of nitazoxanide and mebendazole, processes to prepare it and the use of said composition for the treatment of human parasitosis - Google Patents
Synergistic composition of nitazoxanide and mebendazole, processes to prepare it and the use of said composition for the treatment of human parasitosisInfo
- Publication number
- CO7350656A2 CO7350656A2 CO15081680A CO15081680A CO7350656A2 CO 7350656 A2 CO7350656 A2 CO 7350656A2 CO 15081680 A CO15081680 A CO 15081680A CO 15081680 A CO15081680 A CO 15081680A CO 7350656 A2 CO7350656 A2 CO 7350656A2
- Authority
- CO
- Colombia
- Prior art keywords
- ntzx
- mbdz
- treatment
- composition
- pharmaceutical combination
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica sinérgica para el tratamiento de parasitosis humana de Mebendazol (MBDZ) con Nitazoxanida (NTZX), que amplía significativamente el espectro del MBDZ contra protozoos y refuerza la acción antihelmíntica de la NTZX. Además, al usar dicha combinación farmacéutica de MBDZ y NTZX, la acción sistémica del metabolito activo de la NTZX, la Tizoxanida, y el tratamiento de algunas formas sistémicas de parasitosis, mantienen los mismos efectos de los principios activos individuales. También, la combinación farmacéutica sinérgica de MBDZ con NTZX logra un mayor espectro antiparasitario, mientras mantienen la eficacia y los perfiles de seguridad de ambos principios activos por separado. Todos estos efectos permiten que la combinación farmacéutica de la presente invención se diferencie del resto de los tratamientos antiparasitarios clásicos que tienen espectros más acotados. Los efectos sinérgicos de la combinación farmacéutica MBDZ y NTZX son, por consiguiente, el objeto principal de la presente invención.The present invention relates to a pharmaceutical pharmaceutical composition for the treatment of human parasitosis of Mebendazole (MBDZ) with Nitazoxanide (NTZX), which significantly broadens the spectrum of the MBDZ against protozoa and reinforces the action ; n antihelmintic of the NTZX. In addition, when using such a pharmaceutical combination of MBDZ and NTZX, the systemic action of the active metabolite of NTZX, Thizoxanide, and the treatment of some systematic forms of parasitosis, maintain the same effects of individual active ingredients. Also, the synergistic pharmaceutical combination of MBDZ with NTZX achieves a greater antiparasitic spectrum, while maintaining the efficacy and safety profiles of both active ingredients separately. All these effects allow the pharmaceutical combination of the present invention to be differentiated from the rest of the classic antiparasitic treatments that have more narrow spectra. The synergistic effects of the pharmaceutical combination MBDZ and NTZX are, therefore, the main object of the present invention.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO15081680A CO7350656A2 (en) | 2015-04-13 | 2015-04-13 | Synergistic composition of nitazoxanide and mebendazole, processes to prepare it and the use of said composition for the treatment of human parasitosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO15081680A CO7350656A2 (en) | 2015-04-13 | 2015-04-13 | Synergistic composition of nitazoxanide and mebendazole, processes to prepare it and the use of said composition for the treatment of human parasitosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CO7350656A2 true CO7350656A2 (en) | 2015-08-10 |
Family
ID=54010752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO15081680A CO7350656A2 (en) | 2015-04-13 | 2015-04-13 | Synergistic composition of nitazoxanide and mebendazole, processes to prepare it and the use of said composition for the treatment of human parasitosis |
Country Status (1)
Country | Link |
---|---|
CO (1) | CO7350656A2 (en) |
-
2015
- 2015-04-13 CO CO15081680A patent/CO7350656A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017003151A1 (en) | Formulations for vaccines against neoplasia and methods to prepare them | |
CL2019003589A1 (en) | Derivative of n2, n4-diphenylpyrimidine-2,4-diamine, method for the preparation thereof, and a pharmaceutical composition containing the same as an active ingredient for the prevention or treatment of cancer. | |
MX2020004467A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist. | |
MX2017007321A (en) | Combination therapies. | |
CL2019000935A1 (en) | Pharmaceutical composition, methods for treatment and uses thereof. | |
ECSP17014159A (en) | ADJUNCTIVE THERAPY WITH 25-HYDROXY VITAMIN D | |
CO2020008231A2 (en) | Injectable formulations of botulinum toxin and methods of using them that have a high response rate and a long duration of effect | |
BR112018002530A2 (en) | combinations and uses and treatments of these | |
PH12016501251A1 (en) | A topical composition | |
CL2019000018A1 (en) | Solid forms of a sgc stimulator. | |
EA201791701A1 (en) | DISPENSABLE COMPOSITIONS | |
CO2018012180A2 (en) | Treatment methods for cholestatic and fibrotic diseases | |
BR112017023425A2 (en) | therapeutic combinations of antiviral and anti-inflammatory therapies | |
CO2019015102A2 (en) | New substituted xanthine derivatives | |
NI201500045A (en) | SYNERGIC COMPOSITION OF NITAZOXANIDE AND MEBENDAZOLE, PROCESSES TO PREPARE IT AND THE USE OF SUCH COMPOSITION FOR THE TREATMENT OF HUMAN PARASITOSIS | |
BR112018067453A2 (en) | glycoalkaloid combinations and various uses thereof | |
CL2020001353A1 (en) | Pyrazolopyrimidines that have anti-vsr activity. | |
CO2018004803A2 (en) | Oxa-diazaspiro compounds that have activity against pain | |
CO7350656A2 (en) | Synergistic composition of nitazoxanide and mebendazole, processes to prepare it and the use of said composition for the treatment of human parasitosis | |
PH12018502524A1 (en) | Physiologically balanced injectable formulations of fosnetupitant | |
SV2016005308A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALOPATHIES RELATED TO PAIN, USING AS ACTIVE AGENT TO KETOROLACO TROMETAMINE AND TRAMADOL CHLORHYDRATE | |
DOP2015000068A (en) | SYNERGIC COMPOSITION OF NITAZOXANIDA AND MEBENDAZOL, PROCESSES TO PREPARE IT AND THE USE OF SUCH COMPOSITION FOR THE TREATMENT OF HUMAN PARASITOSIS | |
ECSP15011829A (en) | SYNERGIC COMPOSITION OF NITAZOXANIDE AND MEBENDAZOLE, PROCESSES TO PREPARE IT AND THE USE OF SUCH COMPOSITION FOR THE TREATMENT OF HUMAN PARASITOSIS | |
CL2017001680A1 (en) | Pharmaceutical composition for the treatment of gastrointestinal diseases | |
EA201791483A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MYCOSIS |